Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Italy to take legal action over COVID vaccine delays to secure doses, says minister

01/24/2021 | 09:00am EST

MILAN, Jan 24 (Reuters) - Italy will take legal action against Pfizer and Astrazeneca over delays in deliveries of COVID-19 vaccines with the aim of securing the doses rather than to seek damages, Foreign Minister Luigi Di Maio said on Sunday.

"We are working so our vaccine plan programme does not change. We are activating all channels so the EU Commission does all it can to make these gentlemen respect their contracts," Di Maio said on RAI state television.

(Reporting by Stephen Jewkes; Editing by Edmund Blair)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 2.14% 7005 Delayed Quote.-6.36%
PFIZER INC. 0.17% 34.42 Delayed Quote.-6.57%
All news about ASTRAZENECA PLC
03:23pASTRAZENECA  : The latest news on COVID-19 developments in Canada for March 8
AQ
12:29pTHE LATEST : More than 100,000 have died of COVID-19 in Italy
AQ
11:20aWHO says influenza-like illness post COVID-19 vaccinations expected side effe..
RE
10:46aASTRAZENECA  : Berenberg reiterates its Buy rating
MD
10:21aASTRAZENECA  : Germany looks to AstraZeneca shot to boost vaccine rollout
AQ
07:30aASTRAZENECA  : Italy Green-lights AstraZeneca's COVID-19 Vaccine For People Over..
MT
06:35aASTRAZENECA  : Barclays Lifts AstraZeneca PT, Keeps Overweight Rating
MT
06:11aASTRAZENECA  : Indonesia's Bio Farma To Receive 1.1 Million AstraZeneca COVID-19..
MT
05:38aASTRAZENECA  : Barclays gives a Buy rating
MD
05:38aTHE LATEST : Germany ramps up use of AstraZeneca vaccine
AQ
More news
Financials (USD)
Sales 2021 30 875 M - -
Net income 2021 4 710 M - -
Net Debt 2021 11 049 M - -
P/E ratio 2021 26,2x
Yield 2021 3,01%
Capitalization 125 B 124 B -
EV / Sales 2021 4,39x
EV / Sales 2022 3,84x
Nbr of Employees 76 100
Free-Float 95,8%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 129,45 $
Last Close Price 94,89 $
Spread / Highest target 65,6%
Spread / Average Target 36,4%
Spread / Lowest Target -0,04%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC-6.36%124 268
JOHNSON & JOHNSON-0.81%410 337
ROCHE HOLDING AG-3.56%274 753
PFIZER INC.-6.57%191 873
ABBVIE INC.-0.42%188 420
ELI LILLY AND COMPANY22.55%187 971